vimarsana.com
Home
Live Updates
Sagimet Biosciences to Host Virtual Investor and Analyst Day on Inhibiting Fatty Acid Synthase (FASN) to Reduce Liver Fat, Inflammation and Fibrosis in MASH on May 3, 2024 : vimarsana.com
Sagimet Biosciences to Host Virtual Investor and Analyst Day on Inhibiting Fatty Acid Synthase (FASN) to Reduce Liver Fat, Inflammation and Fibrosis in MASH on May 3, 2024
Sagimet announced positive topline data from its FASCINATE-2 Phase 2b clinical trial of denifanstat in MASH in January 2024 and plans to initiate Phase 3 trial in the second half of 2024SAN MATEO,...
Related Keywords
Brooke Army Medical Center ,
Texas ,
United States ,
San Antonio ,
Joyce Allaire ,
Sagimet Biosciences ,
Stephen Harrison ,
Saint Louis University ,
Exchange Commission ,
Summit Clinical Research ,
University Of Oxford ,
Nasdaq ,
Army Surgeon General ,
Uniformed Services University Of The Health Sciences ,
United States Army ,
Sagimet Biosciences Inc ,
University Of Mississippi School Medicine ,
Pinnacle Clinical Research ,
Education At Brooke Army Medical Center ,
Visiting Professor ,
Radcliffe Department ,
Mississippi School ,
Saint Louis ,
Uniformed Services University ,
Health Sciences ,
Graduate Medical Education ,
Associate Dean ,
Gastroenterology Consultant ,
Army Surgeon ,
Associate Editor ,
Alimentary Pharmacology ,
New England Journal ,
Nature Medicine ,
Lancet Gastroenterology ,
Private Securities Litigation Reform Act ,
Markets ,
vimarsana.com © 2020. All Rights Reserved.